Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.23.2
Condensed Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 39,977 $ 42,634
Accounts receivable (Note 9) 135 1,298
Contract assets and unbilled receivables (Note 9) 2,595 3,552
Prepaids and other current assets 732 1,453
Short-term investments 22 49
Total current assets 43,461 48,986
Property and equipment, net 4 6
Total assets 43,465 48,992
Current liabilities:    
Accounts payable 2,323 1,069
Accrued expenses 3,438 1,684
Total current liabilities 5,761 2,753
Total liabilities 5,761 2,753
Commitments and contingencies (Note 3 and Note 8)
Stockholders' equity    
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of June 30, 2023 and December 31, 2022; no shares issued and outstanding at June 30, 2023 and December 31, 2022. 0 0
Common stock, par value $0.0001; 75,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 20,985,784 and 20,861,315 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively. 2 2
Additional paid-in capital 119,934 117,717
Accumulated deficit (82,232) (71,480)
Total stockholders' equity 37,704 46,239
Total liabilities and stockholders' equity $ 43,465 $ 48,992